ArticleMolecular and clinical oncology2026

Differentiation therapy targeting indoleamine 2,3-dioxygenase 1 in glioblastoma cells

Kaoru Nishide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.